Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma

[1]  P. Validire,et al.  Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth , 2019, Cancer Immunology Research.

[2]  Ying-jian Liang,et al.  Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma. , 2019, Cancer letters.

[3]  Chuanlu Jiang,et al.  DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma , 2019, EBioMedicine.

[4]  R. Zhong,et al.  Association of CCL11, CCL24 and CCL26 with primary biliary cholangitis. , 2019, International immunopharmacology.

[5]  Zechuan Zhang,et al.  The long non-coding RNA Linc-GALH promotes hepatocellular carcinoma metastasis via epigenetically regulating Gankyrin , 2019, Cell Death & Disease.

[6]  Jianren Gu,et al.  Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling , 2019, EBioMedicine.

[7]  Xiaojing Ma,et al.  Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma , 2018, EBioMedicine.

[8]  Yinghao Sun,et al.  Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance of Bladder Cancer , 2018, Clinical Cancer Research.

[9]  G. Scelo,et al.  Epidemiology and Risk Factors for Kidney Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  W. Zhai,et al.  G3BP1 promotes tumor progression and metastasis through IL-6/G3BP1/STAT3 signaling axis in renal cell carcinomas , 2018, Cell Death & Disease.

[11]  G. Peng,et al.  Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer , 2018, Clinical Cancer Research.

[12]  G. Peng,et al.  Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate Cancer , 2017, Clinical Cancer Research.

[13]  M. Kudo,et al.  Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma , 2017, Cancer science.

[14]  L. Qu,et al.  Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling , 2017, Molecular Cancer.

[15]  S. Qiu,et al.  CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis , 2016, Oncotarget.

[16]  F. Liu,et al.  Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer. , 2016, Cancer letters.

[17]  H. Moch,et al.  WHO-ISUP-Graduierungssystem für Nierenkarzinome , 2016, Der Pathologe.

[18]  R. Bast,et al.  Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway , 2016, Oncogene.

[19]  Dajin Li,et al.  Chemokine CCL24 promotes the growth and invasiveness of trophoblasts through ERK1/2 and PI3K signaling pathways in human early pregnancy. , 2015, Reproduction.

[20]  D. Ma,et al.  Gankyrin Is Frequently Overexpressed in Cervical High Grade Disease and Is Associated with Cervical Carcinogenesis and Metastasis , 2014, PloS one.

[21]  Nishant Bhatta,et al.  Gankyrin promotes tumor growth and metastasis through activation of IL‐6/STAT3 signaling in human cholangiocarcinoma , 2014, Hepatology.

[22]  E. Itarte,et al.  HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome. , 2014, Cancer research.

[23]  Nishant Bhatta,et al.  LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/stat3/akt pathway , 2013, Molecular Cancer.

[24]  Stephen Henderson,et al.  The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis , 2013, Clinical Cancer Research.

[25]  P. Weller,et al.  PI3K, ERK, p38 MAPK and integrins regulate CCR3‐mediated secretion of mouse and human eosinophil‐associated RNases , 2013, Allergy.

[26]  M. Schmidt,et al.  The C-C motif chemokine ligands CCL5, CCL11, and CCL24 induce the migration of circulating fibrocytes from patients with severe asthma , 2012, Mucosal Immunology.

[27]  O. Stenina,et al.  Autocrine stimulation of clear-cell renal carcinoma cell migration in hypoxia via HIF-independent suppression of thrombospondin-1 , 2012, Scientific Reports.

[28]  R. Pfundt,et al.  Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. , 2009, Blood.

[29]  T. Sakurai,et al.  The oncoprotein gankyrin interacts with RelA and suppresses NF-κB activity , 2007 .

[30]  G. Ashton,et al.  Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy , 2007, Clinical Cancer Research.

[31]  R. Greil,et al.  Up-Regulation of Functional Chemokine Receptor CCR3 in Human Renal Cell Carcinoma , 2005, Clinical Cancer Research.

[32]  G. Scagliotti,et al.  Wnt/IL‐1β/IL‐8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 , 2019, International journal of cancer.

[33]  Huiyun Zhang,et al.  Upregulated expression of CCR3 in osteoarthritis and CCR3 mediated activation of fibroblast-like synoviocytes. , 2016, Cytokine.

[34]  H. Moch.  [The WHO/ISUP grading system for renal carcinoma]. , 2016, Der Pathologe.

[35]  T. Sakurai,et al.  The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity. , 2007, Biochemical and biophysical research communications.